ARS Pharmaceuticals, Inc. Common Stock
$8.495
USD
Last updated on --.
24h volume651.33K
24h highest8.6260 USD
24h lowest7.9610 USD
24h Price movement+3.98%
SPRY recent prices
24 Hours
+3.98%+$0.325
30 days
+6.99%+$0.555
60 days
+8.70%+$0.68
90 days
-8.46%-$0.785
Key data
Previous close8.1700 USD
Market cap774.57M USD
Volume651.33K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.9900 USD
Net income (FY)-197.71M USD
Revenue (FY)98.99M USD
Last report dateMay 15, 2026
About ARS Pharmaceuticals, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)159.00
Revenue per employee (FY)622.55K USD
Net income per employee (FY)-1.24M USD
Listed onNasdaq
SPRY conversion tables
 |  |
|---|---|
| 0.5 SPRY | 4.247 USD |
| 1 SPRY | 8.495 USD |
| 5 SPRY | 42.47 USD |
| 10 SPRY | 84.95 USD |
| |
|---|---|
| 0.5 USD | 0.058858 SPRY |
| 1 USD | 0.11772 SPRY |
| 5 USD | 0.58858 SPRY |
| 10 USD | 1.177 SPRY |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
SPRY is trading at $8.495, +3.98% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SPRY stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SPRY is currently trading at $8.495, +3.98% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SPRY price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SPRY's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SPRY; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SPRY's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
ARS Pharmaceuticals, Inc. Common Stock's market cap is currently 774.57M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume651.33K
24h highest8.6260 USD
24h lowest7.9610 USD
24h Price movement+3.98%
Start trade with SPRY Perpetual
Sign up to trade